Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1

Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Qualitative Stage

This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment.

This study will inform a set of 'attributes' and their levels that can be used in a later discrete choice experiment (DCE), for which separate ethical approval will be sought, to assess the trade-offs patients are willing to make between breast-related side effects, other quality of life (QOL) impacts and cancer control.

Inclusion Criteria:

• Men with high-risk BCR PCa but no ADT+/-ARPI experience.
• Men with ADT+/-ARPI experience who have experienced breast-related side effects from this treatment.

Exclusion Criteria:

• Men receiving psychiatric care as a consequence of their prostate cancer diagnosis or treatment thereof.